The founder of Dover Financial Advisers will never work in the industry again, he has told the Australian Securities and Investments Commission as part of a court-enforceable undertaking that also strips the firm of its operating licence.
In a landmark ruling, the World Trade Organisation has backed Australia’s controversial law imposing plain packaging on tobacco products, finding the law did not violate intellectual property rights.
A ruling in a trademark battle between two beverage giants over a shade of green is set to be handed down next week, and the decision could provide fresh guidance on what a company needs to do to successfully claim a colour as a ‘badge of origin’.
The Australian Securities and Investments Commission has banned former NAB advisor Graeme Cowper from offering financial services for four years, after an investigation found he was not up to the job.
Kmart has filed its defence denying claims in a suit alleging CEO Guy Russo gave false assurances that the department store had revamped a line of cargo pants and shorts that infringed the copyright of Australian streetwear manufacturer Globe International.
A Toyota supervisor’s “overly sexualised” remarks to young female workers were a “blatant form of benevolent sexism”, the Fair Work Commission has found in upholding the car maker’s dismissal of the long-time employee.
AMP’s financial planning unit was hit Wednesday with an enforcement action by the corporate regulator alleging its planners generated extra commissions by replacing, rather than transferring, life insurance policies for existing clients.
Herbert Smith Freehills has prevailed in a suit by United Petroleum alleging the law firm and former United chairman Martin Hudson breached their duties to the company when they pulled a planned initial public offering in 2016.
Regulating third-party litigation funders gets a resounding yes, but experts are divided on removing the ban on contingency fees and other recommendations for reforming the class action regime. Lawyerly spoke to defence and plaintiff-side lawyers, as well as funders, for their take on the recent proposals, and five major talking points emerged.
The Australian Competition and Consumer Commission is seeking special leave from the High Court to appeal a ruling in a case alleging drug giant Pfizer misused its market power ahead of the expiration of its patent for Lipitor.